Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating a new pacing method for heart failure patients

Official title: Acute Response to Left Bundle Branch Area Pacing With SyncAV

Run by Abbott Medical Devices · NCT06436053 · Data updated 2026-11-12

This study is testing a new pacing method for heart failure patients to see if it can improve their heart function.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorAbbott Medical Devices
Industry-sponsored
Locations1 site (San Donato Milanese, MI)
StatusRecruiting
StartedMay 15, 2024
Main results expectedDecember 15, 2026
Study endsJuly 15, 2027
Registry record updatedJuly 9, 2026
Trial IDNCT06436053 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with left bundle branch block or intraventricular conduction delay who require dual-chamber pacing or cardiac resynchronization therapy.

Probably not a fit

Patients with high resting heart rates, significant AV block, or recent cardiac events may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation is a prospective, single-arm, post-market study that aims to assess the effectiveness of the SyncAV dynamic atrioventricular delay feature in conjunction with left bundle branch area pacing (LBBAP) for patients with heart failure. The study will involve patients who are scheduled to receive an Abbott pacing system and have specific conduction abnormalities. By monitoring the outcomes of these patients, the study seeks to provide insights into the benefits of this pacing approach in improving heart function.

Why it matters

Potential benefit: If successful, this approach could enhance heart function and quality of life for patients with heart failure.

How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving outcomes for heart failure patients with pacing interventions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient is 18 years of age and willing to comply with the study requirements
2. Patients with approved indication for dual-chamber pacing or cardiac resynchronization therapy and scheduled to be implanted with an Abbott pacing system
3. Patient has documented left bundle branch block (LBBB) or intraventricular conduction delay (IVCD)
4. Patient has an intrinsic QRS duration ≥ 130 ms
5. Patient has intact AV conduction with PR interval ≤ 250 ms

Exclusion Criteria:

1. Patient has a resting ventricular rate \> 100 bpm
2. Patient has AV Block (2nd or 3rd degree)
3. Patient has documented persistent atrial tachycardia or atrial fibrillation
4. Patient has had a recent myocardial infarction, ablation, electrolyte imbalance, or any condition within the last 90 days that would contraindicate for pacing device programming changes in the opinion of the investigator
5. Patient is currently participating in another clinical investigation
6. Patient is pregnant or nursing
7. Patient has other medical, anatomic, comorbid, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results
8. Patient does not have legal authority
9. Patient is unable to read or write

Where it's running

  • I.R.C.C.S. Policlinico San Donato
    San Donato Milanese, Mi, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.